Overview of Therapeutic Effects of Statins on Inflammatory Diseases Through Regulating Adhesive Molecules

Curr Stem Cell Res Ther. 2020;15(7):614-622. doi: 10.2174/1574888X15666200225092749.

Abstract

Simvastatin, lovastatin, rosuvastatin, pravastatin and cerivastatin belong to the statin family, which are competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A. As the rate-limiting enzyme in the pathway of cholesterol metabolism, statins are classically prescribed to patients as lipidlowering agents. However, statins also possess several extra bioactivities, including anti-inflammatory, antiviral and anti-tumor. Interestingly, the most essential mechanism of these activities is that statins could regulate the expression of cell adhesion molecules (CAMs), especially, targeting lymphocytes function-associated molecules (LFA)-1, macrophage (Mac)-1 and intercellular adhesion molecules (ICAM)-1. Therefore, in this paper, we discussed the regulatory effect of statins on CAMs among different diseases. In addition, we provided speculation for the role of statins in treating orthopedic disease.

Keywords: CAM; LFA-1; Mac-1; Statins; cardiovascular disease.; inflammation.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Adhesion Molecules / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / chemistry
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Inflammation / drug therapy*
  • Models, Biological
  • Molecular Weight

Substances

  • Cell Adhesion Molecules
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors